Oric Pharmaceuticals, Inc. (ORIC)
11.11
-0.22
(-1.94%)
USD |
NASDAQ |
Feb 20, 16:00
10.70
-0.41
(-3.69%)
After-Hours: 20:00
Oric Pharmaceuticals Shareholders Equity (Quarterly) : 406.92M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 81.54B |
| Pfizer Inc. | -- |
| Krystal Biotech, Inc. | 1.220B |
| Olema Pharmaceuticals, Inc. | 307.49M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 431.19M |
| Total Liabilities (Quarterly) | 24.27M |
| Debt to Equity Ratio | 0.0081 |
| Current Ratio | 14.65 |
| Net Debt Paydown Yield | -0.01% |